secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2026-10-02T12:00:14+00:00
Accession:  0001683168-26-007552
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

CNS Pharmaceuticals holders approve 650,000-share Equity Plan increase; six directors elected at annual meeting
--------------------------------------------------------------------------------

- Stockholders approved amending the 2020 Equity Plan to add 650,000 shares, raising total shares authorized for issuance to 765,061 from 115,061; vote was 96,953 for, 8,128 against, 35 abstain.
- Rami Levin, Amy Mahery, Faith Charles, Bettina Cockroft, Michal Fisher and Jeffrey Keyes elected directors to serve until the 2027 annual meeting; each received between 100,524 and 102,460 votes for.
- MaloneBailey, LLP ratified as independent registered public accounting firm for the year ending December 31, 2026: 637,228 for, 30,874 against, 89 abstain.
- Advisory say-on-pay resolution approved with 98,103 for and 6,682 against; adjournment-of-meeting proposal authorized 622,421 for vs 45,635 against.
- Annual meeting held September 30, 2026 with 668,188 shares (45.72%) present by proxy or in person, constituting a quorum; 1,461,449 shares outstanding at the August 10, 2026 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316826007552/0001683168-26-007552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316826007552/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-007552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer